LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	PD173074	3.33	uM	LJP6	72	hr	1097	4036	3673	1.0993	1.1117
BT-20	PD173074	10	uM	LJP6	72	hr	1097	3261	3673	0.8879	0.8681
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1097	3340	3846	0.8681	0.8491
BT-20	Crizotinib	0.12	uM	LJP5	72	hr	1097	3563	3846	0.9263	0.9168
BT-20	Crizotinib	0.37	uM	LJP5	72	hr	1097	3267	3846	0.8493	0.8271
BT-20	Crizotinib	1.11	uM	LJP5	72	hr	1097	2992	3846	0.7779	0.7407
BT-20	Crizotinib	3.33	uM	LJP5	72	hr	1097	1566	3846	0.4068	0.2150
BT-20	Crizotinib	10	uM	LJP5	72	hr	1097	1085	3846	0.2822	-0.0064
BT-20	BMS345541	0.04	uM	LJP6	72	hr	1097	3601	3673	0.9804	0.9774
BT-20	BMS345541	0.12	uM	LJP6	72	hr	1097	3421	3673	0.9312	0.9190
BT-20	BMS345541	0.37	uM	LJP6	72	hr	1097	3237	3673	0.8811	0.8590
BT-20	BMS345541	1.11	uM	LJP6	72	hr	1097	2809	3673	0.7641	0.7119
BT-20	BMS345541	3.33	uM	LJP6	72	hr	1097	2738	3673	0.7449	0.6880
BT-20	BMS345541	10	uM	LJP6	72	hr	1097	711	3673	0.1935	-0.2207
BT-20	KIN001-043	0.04	uM	LJP6	72	hr	1097	3507	3673	0.9551	0.9480
BT-20	KIN001-043	0.12	uM	LJP6	72	hr	1097	3483	3673	0.9487	0.9403
BT-20	KIN001-043	0.37	uM	LJP6	72	hr	1097	3628	3673	0.9879	0.9861
BT-20	KIN001-043	1.11	uM	LJP6	72	hr	1097	3817	3673	1.0388	1.0438
BT-20	KIN001-043	3.33	uM	LJP6	72	hr	1097	3298	3673	0.8985	0.8802
BT-20	KIN001-043	10	uM	LJP6	72	hr	1097	1621	3673	0.4415	0.2511
BT-20	Saracatinib	0.04	uM	LJP6	72	hr	1097	3499	3673	0.9530	0.9455
BT-20	Saracatinib	0.12	uM	LJP6	72	hr	1097	3436	3673	0.9357	0.9248
BT-20	Saracatinib	0.37	uM	LJP6	72	hr	1097	3174	3673	0.8645	0.8398
BT-20	Saracatinib	1.11	uM	LJP6	72	hr	1097	2888	3673	0.7863	0.7422
BT-20	Saracatinib	3.33	uM	LJP6	72	hr	1097	2338	3673	0.6361	0.5414

|<
<<
Previous
Page 89 of 166
Next
>>
>
2201 to 2225 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)